# Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

> **NCT06397859** · — · RECRUITING · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 266 (estimated)

## Conditions studied

- Hepatitis D

## Interventions

- **DRUG:** Bulevirtide

## Key facts

- **NCT ID:** NCT06397859
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-06
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06397859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06397859, "Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06397859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*